These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9585816)

  • 41. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
    Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
    Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses.
    Hengel H; Lindner M; Wagner H; Heeg K
    J Immunol; 1987 Dec; 139(12):4196-202. PubMed ID: 2826584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoprotein C varies between individual mice and is dependent on the form of immunization.
    Martin S; Mercadal CM; Weir JP; Rouse BT
    Viral Immunol; 1993; 6(1):21-33. PubMed ID: 8386515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allorestricted cytotoxic T cells. Large numbers of allo-H-2Kb-restricted antihapten and antiviral cytotoxic T cell populations clonally develop in vitro from murine splenic precursor T cells.
    Reimann J; Kabelitz D; Heeg K; Wagner H
    J Exp Med; 1985 Aug; 162(2):592-606. PubMed ID: 2991416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen-independent activation of memory cytotoxic T cells by interleukin 2.
    Lefrancois L; Klein JR; Paetkau V; Bevan MJ
    J Immunol; 1984 Apr; 132(4):1845-50. PubMed ID: 6230394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis.
    Wang J; Charboneau R; Barke RA; Loh HH; Roy S
    J Immunol; 2002 Oct; 169(7):3630-6. PubMed ID: 12244154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Herpes simplex virus type 1 and 2 in the adrenal glands: replication and histopathology.
    Potratz D; Brake B; Dienes HP; Schulz TF; Hosp M; Dierich MP; Falke D
    Arch Virol; 1986; 90(3-4):207-22. PubMed ID: 3015081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus.
    Bartholdy C; Christensen JP; Wodarz D; Thomsen AR
    J Virol; 2000 Nov; 74(22):10304-11. PubMed ID: 11044074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the capacity of B cells as well as T cells to serve as accessory cells for the activation of herpes simplex virus-specific cytolytic T cells.
    Grammer SF; Ishioka GY; Chesnut RW
    J Immunol; 1988 Mar; 140(6):2016-22. PubMed ID: 2831277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HSV induces an early primary Th1 CD4 T cell response in neonatal mice, but reduced CTL activity at the time of the peak adult response.
    Evans IA; Jones CA
    Eur J Immunol; 2005 May; 35(5):1454-62. PubMed ID: 15789359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
    Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
    J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dendritic cells exposed to herpes simplex virus in vivo do not produce IFN-alpha after rechallenge with virus in vitro and exhibit decreased T cell alloreactivity.
    Björck P
    J Immunol; 2004 May; 172(9):5396-404. PubMed ID: 15100280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections.
    Freeman ML; Sheridan BS; Bonneau RH; Hendricks RL
    J Immunol; 2007 Jul; 179(1):322-8. PubMed ID: 17579052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-gamma.
    Horvath-Arcidiacono JA; Mostowski HS; Bloom ET
    Int Immunol; 1996 May; 8(5):661-73. PubMed ID: 8671653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
    Mohamedi SA; Brewer JM; Alexander J; Heath AW; Jennings R
    Vaccine; 2000 Apr; 18(20):2083-94. PubMed ID: 10715522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.